News and Comments

Biotech Firms with Guaranteed Growth Potential

  Thursday, July 07, 2016

Good news is not always great news that makes a difference. In the drug industry, clinical trial results that demonstrate a drug has fulfilled the requirements of the trials, including the primary and secondary endpoints does not always guarantee that the drug will be successful if and when it hits the market. Experience and follow up on certain firms enables us to see the real light at the end of the tunnel, not just celebrate reaching the end of it without knowing what to expect outside. This makes a big difference.  More...

THERAVANCE: BECAME TEMPTING TO INVESTORS ANR TO ITS PARTNER

  Monday, January 07, 2013

Using scientific skills towards building pipelines of promising products does not guarantee a happy ending for a small biotech firm. Pipelines’ breakthroughs need managements’ capabilities and swiftness of actions, which would walk them through the safest and fastest road towards approvals.  We believe Theravance (THRX) has benefited from both its scientists and management. The firm has come nearer than ever to reaching a happy beginning of substantial growth, or perhaps, a happy ending through acquisition, probably, by its partner GlaxoSmithKline (GSK).  More...


Recent Postings


Archive


Tags

Prosensa (RNA) Agenus (AGEN) MODERNA Inovio (INO) Seattle Genetics (SGEN) Abbott Laboratories (ABT) IDERA (IDRA) REGULUS (RGLS) Alnylam (ALNY) Herceptin JUNO (JUNO) GlaxoSmithKline (GSK) AstraZeneca (AZN) Cytokinetics (CYTK) C4 Therapeutics GUARDIAN HEALTH Array Pharmaceuticals (ARRY) ARGOS (ARGS) galapagos (GLPG) OSI (OSIP) NEKTAR (NKTR)) ADVENTRIX (ANX) TOKAI (TKAOI) SERES THERAPEUTICS (MCRB) Regeneron (REGN) NOVOCURE (NVCR) VANDA (VNDA) Vitae Pharmaceuticals (VTAE) Velcade (bortezomib) HALOZYME (HALO) Trastuzumab-DM1 ISIS (ISIS) Intrexon (XON) Ridaforolimus ImmunoGen (IMGN) Gilead (GILD) Roche (ROCHE) Adaptimmune (ADAP) Sanofi-Aventis (SAN) Biogen Idec (BIIB) KERYX (KERX) Spike Therapeutics (ONCE) Human Genome Sciences (HGSI) Bristol-Myers Squibb (BMY) CEMPRA (CEMP) Ariad (ARIA) Multiple Myeloma KITE (KITE) PORTOLA (PTLA) Biocryst (BCRX) Sanofi (SNA) Ziofpharm (ZIOP) Xoma (XOMA) CompuGen (CGEN) Auspex (ASPX) Sanofi (SNY) RenenxBio (RGNX) Agenus (AGEN Sequenom (SQNM) Theravance (THRX) Sarepta (SRPT) Anacor (ANAC) BIOMARIN (BMRN) Anadys (ANDS) Exelixis (EXEL) Revlimid (lenolidamide) Zerenex INNOVIVA (INVA) SYNTA (SNTA) Merck (MRK) ACADIA (ACAD) Onyx (ONXX) Micromet (MITI) Prolor Biotech (PBTH) Bellicum (BLCM) Amgen (AMGN) Roche (RHHBY) ZALTRAP™ Valeant Pharmaceuticals International (VRX) Sangamo (SGMO) Galena (GALE) Tysabri Dendreon (DNDN) Genentech Elan (ELN) Ionis (IONS) Global Cell Therapeutics (GBT) ABBVIE (ABBV) CRISPR Therapeutics (CRSP) NANTKWEST (NK) Illumina (ILMN) AERIE PHARMACEUTICALS Pluristem (PSTI) Dynavax (DVAX) Aimmune Therapeutics (AIMT) Telaprevir Rapamune SUNESIS PHARMACEUTICALS (SNSS) Editas (EDIT) Jazz Pharmaceuticals (JAZZ) Incyte (INCY) Endometrial Cancer ARCA (ABIO) Theravance Bio Pharma (TBPH) Vertex (VRTX) Benlysta (belimumab) Intermune (ITMN) Alder Biopharmaceuticals (ALDR) Intercept (ICPT) Human Longevity (HLI) Ocular Therapeutix (OCUL) Mirati Therapeutics (MRTX) Advaxis (ADXS) PTC Therapeutics (PTCT) AGOS (ARGS) Idenix (IDIX)